Orion Group Holdings, Inc.
NYSE:ORNEngineering & Construction
+$0.48 today
- Market cap
- $300.07M
- Beta
- 1.38
- P/E (TTM)
- 73.6
- EPS (TTM)
- $0.21
Volume 0.92M
Average 0.34M
ORN Other Non-Cash Items
Other non-cash adjustments that reconcile net income to operating cash flow.
Orion Group Holdings, Inc.NYSE: ORN
Other Non-Cash Items · Q1 FY2026 · quarter ended Mar 2026
Other non-cash items growth accelerates
Q1 FY2026 other non-cash items of $2.03M rose 670.5% year over year, ahead of the +164.1% change in trailing-twelve-month other non-cash items.
Context
- Other non-cash items amounted to 0.8% of revenue in FY2025, up 0.7 pp from a year earlier.
- Other non-cash items increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +670.5% holds above the trailing-twelve-month pace of +164.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Non-Cash Items history
USD · from the cash flow
- Latest · FY2025
- 6.7M USD
- Year-over-year change
- +1072.6%
| Period | Period end | Other Non-Cash Items | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.7M | +1072.6% |
| FY2024 | 2024-12-31 | (689K) | -1229.5% |
| FY2023 | 2023-12-31 | 61K | +101.4% |
| FY2022 | 2022-12-31 | (4.22M) | +58.6% |
| FY2021 | 2021-12-31 | (10.2M) | — |
Other Non-Cash Items vs competitors
How ORN compares with its peers on the latest reported figures
- Peers report in different currencies, so other non-cash items is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +164.1% is the 6th highest of 10, against a peer median of +167.6%.
- Other non-cash items amounts to 0.3% of revenue for ORN, versus a peer median of 8.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $162.03M USD | +3022.6% | +176.8% | 10.5% | |
| LTM Mar 2026 | £118.6M GBP | — | +464.6% | — | |
| LTM Apr 2026 | $55.27M USD | +167.6% | — | 10.6% | |
SRTAStrata Critical Medical, Inc. | LTM Mar 2026 | $25.92M USD | -276.9% | +67.1% | 10.2% |
| LTM Mar 2026 | $24.59M USD | -47.9% | +158.0% | 132.5% | |
| LTM Mar 2026 | $6.32M USD | -780.8% | +20.4% | 8.6% | |
| LTM Apr 2026 | $4.77M USD | -19.6% | — | 1.2% | |
| LTM Feb 2026 | $3.38M USD | +391.1% | +32.3% | 2.8% | |
| LTM Mar 2026 | $2.76M USD | +164.1% | — | 0.3% | |
| LTM Feb 2026 | $2.67M USD | +4404.8% | — | 0.7% | |
| LTM Mar 2026 | $2.45M USD | +257.1% | — | 0.3% | |
| Peer median (excluding ORN) | — | +167.6% | +112.5% | 8.6% | |
Competitors are the stored peer set for ORN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (14.56M) | (12.61M) | (17.88M) | (1.64M) | 2.49M |
| Depreciation & Amortization | 30.53M | 28.87M | 30.64M | 32.73M | 21.94M |
| Deferred Income Tax | (9K) | 13K | (103K) | (27K) | 52K |
| Stock-Based Compensation | 2.4M | 2.75M | 2.04M | 4.01M | 5.45M |
| Change in Working Capital | (8.1M) | (5.24M) | 2.41M | (21.7M) | (8.56M) |
| Accounts Receivables | 8.46M | (44.03M) | (23.71M) | (850K) | (32.76M) |
| Inventory | 371K | (1.49M) | (729K) | (554K) | 787K |
| Accounts Payables | 589K | 39.37M | (4.51M) | 16.02M | 11.09M |
| Other Working Capital | (17.52M) | 910K | 31.36M | (36.31M) | 12.33M |
| Other Non-Cash Items | (10.2M) | (4.22M) | 61K | (689K) | 6.7M |
| Operating Cash Flow | 69K | 9.57M | 17.18M | 12.68M | 28.07M |
| Capital Expenditures | (16.98M) | (14.58M) | (8.91M) | (14.09M) | (38.86M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 27.6M | 4.88M | 11.08M | 2.61M | 25.16M |
| Investing Cash Flow | 10.63M | (9.7M) | 2.17M | (11.48M) | (13.7M) |
| Debt Repayment | 845K | (7.27M) | 14.84M | (30.26M) | (42.32M) |
| Common Stock Issued | 0 | 0 | 0 | 26.42M | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (839K) | (1.1M) | (7.03M) | 25K | 2.93M |
| Financing Cash Flow | 6K | (8.37M) | 7.81M | (3.82M) | (39.39M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 10.7M | (8.51M) | 27.15M | (2.62M) | (25.03M) |
| Free Cash Flow | (16.91M) | (5.02M) | 8.27M | (1.42M) | (10.8M) |
Orion Group Holdings, Inc.
NYSE:ORN
Intrinsic Alpha fair value
Locked
Current Price
$7.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.